most interesting articles
News Center
2018-07-03
Melanotan sustained release products
Australian EpiTan company has applied for new international patents for all the sustained-release dosage forms of its leading product Melanotan, The patent application covers a variety of existing sustained-release dosage forms, including subcutaneous imp
2018-08-25
Bremelanotide for use in hyposexuality in premenopausal women
U.S. FDA approves Vyleesi (Bremelanotide) for use in hyposexuality in premenopausal women
2019-1-10
Anti-aging and anti-wrinkle peptide - Palmitoyl pentapeptide-4
Palmitoyl pentapeptide-4, cosmetic peptide, Palmitoyl Pentapeptide-3